{"DataElement":{"publicId":"7850272","version":"1","preferredName":"COVID-19 Infection Medication Administered Other Specify Text","preferredDefinition":"Other medications taken to treat the COVID-19 infection than those previously specified.","longName":"COV_MED_ADM_OTH_SPEC","context":"NIH","contextVersion":"1","DataElementConcept":{"publicId":"7850268","version":"1","preferredName":"COVID-19 Infection Medication Administered","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product._The act of having given something (e.g., a medication or test).","longName":"7850310v1.0:2233610v1.0","context":"NIH","contextVersion":"1","ObjectClass":{"publicId":"7850310","version":"1","preferredName":"COVID-19 Infection Medication","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.:A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","longName":"C171133:C459","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B9A870-4F8E-35D3-E053-4EBD850A1754","latestVersionIndicator":"Yes","beginDate":"2021-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-09","modifiedBy":"ONEDATA","dateModified":"2021-12-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B85353-2B2B-54FE-E053-4EBD850A7853","latestVersionIndicator":"Yes","beginDate":"2021-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-09","modifiedBy":"KUMMEROA","dateModified":"2022-02-14","changeDescription":"2022-2-14 ak Released per DW review. 2021-12-9 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2857322","version":"1","preferredName":"Other Specify Text","preferredDefinition":"The free text field that describes another response when other is chosen from a list of values.","longName":"OTHR_SPEC_TXT","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2857047","version":"1","preferredName":"Other Specify Text","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.:Text; the words of something written.","longName":"C17649:C25685:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"660AABE0-46ED-4890-E040-BB89AD431D5B","latestVersionIndicator":"Yes","beginDate":"2009-03-26","endDate":null,"createdBy":"SCOTTLO","dateCreated":"2009-03-26","modifiedBy":"ONEDATA","dateModified":"2009-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6648A78E-AB33-047A-E040-BB89AD4324AB","latestVersionIndicator":"Yes","beginDate":"2009-03-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-03-29","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/22/17 tt transferred context, added registration status and CSI per Round 5 finalization task. Modified for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg (JP) 12/2010.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"7244861","version":"1","longName":"COVID-19","context":"NCIP","ClassificationSchemeItems":[{"publicId":"8038915","version":"1","longName":"NIH","context":"NCIP"},{"publicId":"8038916","version":"1","longName":"Project 5 CDEs","context":"NCIP"}]},{"publicId":"7977821","version":"1","longName":"Project 5 COVID","context":"NIH","ClassificationSchemeItems":[{"publicId":"7977823","version":"1","longName":"Tier 1","context":"NIH"}]}],"AlternateNames":[{"name":"COVID-19 Specific Medication Specify Other Type","type":"NIH COVID","context":"NIH"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Other COVID-19-Specific Medic","type":"Preferred Question Text","description":"Other COVID-19-Specific Medication, Specify:","url":null,"context":"NIH"},{"name":"COG CRF text 1","type":"Alternate Question Text","description":"If other, specify:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2B883AC-9442-4E99-E053-4EBD850AD6E1","latestVersionIndicator":"Yes","beginDate":"2021-12-09","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-09","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-14 ak Released per DW review. 2021-12-9 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}